Pfizer and BioNTech to seek backing for COVID-19 booster in all U.S. adults aged 18 and over, as deaths still average 1,200 a day
November 09, 2021 at 10:56 AM EST
Pfizer and German partner BioNTech are planning to seek authorization for their COVID-19 vaccine booster shot for anyone aged 18 and over living in the U.S., according to a new report, a move that would greatly expand the program and boost protection levels.
